Becton, Dickinson and Company (BDXB) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Instruments & Supplies 산업에서 운영. 본사 소재지는 Franklin Lakes, NJ, 미국. 현재 CEO는 Thomas E. Polen Jr..
BDXB 을(를) 보유 IPO 날짜 2020-05-21, 77,000 명의 정규직 직원, 에 상장 NYSE, 시가총액 $13.69B.
Becton, Dickinson and Company is a global leader in medical technology, developing, manufacturing, and distributing a comprehensive portfolio of medical supplies, devices, laboratory equipment, and diagnostic products. The company serves healthcare institutions, physicians, life science researchers, clinical laboratories, and the pharmaceutical industry through three primary business segments: BD Medical, which provides IV catheters, infusion systems, syringes, diabetes care products, and medication management solutions; BD Life Sciences, which offers specimen collection, microbiology automation, molecular testing systems, and cell analysis instruments; and BD Interventional, which specializes in surgical products, grafts, and critical care devices. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, Becton Dickinson operates worldwide to advance patient care and clinical outcomes across multiple healthcare settings.
